Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABT-072 is a nonnucleoside NS5B polymerase inhibitor and a candidate drug evaluated for treatment of hepatitis C virus.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 1,780.00 | |
50 mg | 10-14 weeks | $ 2,320.00 | |
100 mg | 10-14 weeks | $ 3,520.00 |
Description | ABT-072 is a nonnucleoside NS5B polymerase inhibitor and a candidate drug evaluated for treatment of hepatitis C virus. |
In vitro | ABT-072 inhibits non-nucleoside NS5B polymerase. And it yields antiviral effects[1]. |
Molecular Weight | 469.55 |
Formula | C24H27N3O5S |
CAS No. | 1132936-00-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABT-072 1132936-00-5 Others ABT072 ABT 072 inhibitor inhibit